Cigna Group $CI Shares Sold by Nepsis Inc.

Nepsis Inc. reduced its stake in Cigna Group (NYSE:CI) by 4.5% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 38,840 shares of the health services provider’s stock after selling 1,850 shares during the period. Cigna Group accounts for approximately 3.6% of Nepsis Inc.’s investment portfolio, making the stock its 17th largest position. Nepsis Inc.’s holdings in Cigna Group were worth $11,196,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of CI. Massachusetts Financial Services Co. MA grew its holdings in shares of Cigna Group by 1.1% in the second quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock valued at $3,893,727,000 after purchasing an additional 123,479 shares during the period. Dodge & Cox boosted its holdings in Cigna Group by 0.7% in the 2nd quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock valued at $2,958,893,000 after purchasing an additional 60,877 shares during the last quarter. Valeo Financial Advisors LLC grew its stake in shares of Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after buying an additional 3,471,249 shares during the period. Norges Bank purchased a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $1,110,426,000. Finally, Arrowstreet Capital Limited Partnership increased its holdings in shares of Cigna Group by 24.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after buying an additional 492,045 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In other news, CEO David Cordani acquired 4,134 shares of Cigna Group stock in a transaction dated Monday, November 3rd. The shares were acquired at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Price Performance

CI stock opened at $279.13 on Friday. The business’s fifty day moving average price is $272.31 and its 200 day moving average price is $289.13. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $74.56 billion, a PE ratio of 12.31, a P/E/G ratio of 1.00 and a beta of 0.26.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The business had revenue of $69.57 billion during the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter last year, the business posted $7.51 EPS. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.2%. The ex-dividend date was Thursday, December 4th. Cigna Group’s payout ratio is 26.64%.

Wall Street Analyst Weigh In

A number of research firms recently commented on CI. Robert W. Baird decreased their price objective on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. Cowen set a $333.00 price target on Cigna Group in a research note on Monday, December 15th. Mizuho set a $325.00 price target on Cigna Group in a report on Friday. Truist Financial boosted their price objective on shares of Cigna Group from $310.00 to $320.00 and gave the company a “buy” rating in a report on Monday. Finally, Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $330.48.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.